- $25.84m
- $2.97m
- $52.38m
- 74
- 89
- 43
- 78
Annual income statement for Investview, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 24.2 | 38.3 | 61.8 | 67.9 | 52.4 |
Cost of Revenue | |||||
Gross Profit | 21.7 | 30.7 | 53.6 | 57.2 | 46.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 35.4 | 32 | 70.5 | 63.3 | 51.1 |
Operating Profit | -11.3 | 6.25 | -8.61 | 4.6 | 1.32 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.3 | 0.715 | -12.6 | 5.01 | 2.09 |
Provision for Income Taxes | |||||
Net Income After Taxes | -21.3 | 0.566 | -12.9 | 2.83 | 1.19 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -21.3 | 0.566 | -12.9 | 2.83 | 1.19 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -21.3 | 0.344 | -13.8 | 2.01 | 0.372 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.007 | -0.001 | -0.002 | 0.001 | 0.001 |